CClinicalTrials.gg
WithdrawnNCT01148082Updated Jun 26, 2017

School Response to Families Who Have Children With Cancer

An observational study in Carcinomas, Squamous Cell Carcinoma and Adenocarcinoma, sponsored by Stanford University. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-06-26.

Sponsored by Stanford University · Observational

Why this study was withdrawn
Business decision
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
0
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research is to investigate school response to families who have children with cancer. It is anticipated that the results of this study will enhance the support that schools can give to the population of families who have a child with cancer. The study will involve the parents in these families, the principal and an educator in the school of the child with cancer. Measurement tools will include surveys, interviews, and other relevant educational and medical documents.

02

Conditions studied

  • Carcinomas
  • Squamous Cell Carcinoma
  • Adenocarcinoma

Keywords

  • Carcinomas (including Squamous Cell and Adenocarcinoma)
03

In context

Carcinoma

6,741 studies on the registry are indexed under Carcinoma; 1,161 are open to participants now.

Browse Carcinoma studies →

Lead sponsor

Stanford University is the lead sponsor of 2,117 studies on the registry; 425 are open to participants now.

Of its 259 completed or terminated interventional studies of FDA-regulated products, 197 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Prospective participants will be parents/caregivers who have had school-age children treated for cancer within the last 5 years

Eligibility criteria

Inclusion Criteria:

  • Patients will not be recruited. Only parents, the school principals and the teachers will be recruited.
  • Subjects will be 15 sets of parents who have had school-age children treated for cancer within the last 5 years.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
0 participants (actual)

Interventions

  • ProcedureSelf administered Surveys
  • ProcedureInterviews
06

What researchers measure

Primary outcomes

  1. Evidence of support

    Identify significant patterns. Documents, interview, surveys and the quantitative instrument will be analyzed with an inductive cross-case analysis. Inductive analysis means that the patterns, themes, and categories emerged out of the data rather than being imposed on them prior to data collection and analysis. A cross-case analysis means that the information will be grouped together according to answers from different people, themes, perspectives or issues. Then, a content analysis will be conducted which includes the process of identifying, coding, and categorizing the primary patterns in the data. In the final step, the data will be interpreted. Interpretation, by definition, goes beyond description. Interpretation means attaching significance to what was found offering explanations, drawing conclusions, making inferences, building linkages, attaching meaning, imposing order and dealing with rival explanations

    Time frame: one time

07

Study locations

1 site
  • Stanford University School of Medicine
    Stanford, California 94305, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 26, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01148082
Lead sponsor
Stanford University
Responsible party
Sponsor
First posted
Jun 22, 2010
Start date
Sep 2010 (estimated)
Primary completion
Jul 2011 (estimated)
Completion
Jul 2011 (estimated)
Last update
Jun 26, 2017

Study contacts

Michael Link
principal investigator · Stanford University
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion